29 Jan 2025
// PR NEWSWIRE
01 Jan 2025
// FDA
18 Dec 2024
// PR NEWSWIRE
Latest Content by PharmaCompass
Reset all filters
01 2ACETAZOLAMIDE
02 6AMITRIPTYLINE HYDROCHLORIDE
03 2APIXABAN
04 3ASENAPINE MALEATE
05 2BENDAMUSTINE HYDROCHLORIDE
06 1BRETYLIUM TOSYLATE
07 1CABAZITAXEL
08 2CARFILZOMIB
09 3DABIGATRAN ETEXILATE MESYLATE
10 4DULOXETINE HYDROCHLORIDE
11 2ENTECAVIR
12 1EPINASTINE HYDROCHLORIDE
13 2EPLERENONE
14 2ESTRADIOL; NORETHINDRONE ACETATE
15 7EVEROLIMUS
16 1EXEMESTANE
17 4FLUPHENAZINE HYDROCHLORIDE
18 1LAMIVUDINE
19 1METHADONE HYDROCHLORIDE
20 2METHSCOPOLAMINE BROMIDE
21 1METHYLERGONOVINE MALEATE
22 1MIGLUSTAT
23 1MONTELUKAST SODIUM
24 1NOREPINEPHRINE BITARTRATE
25 3OMEPRAZOLE
26 3OXCARBAZEPINE
27 1PENICILLAMINE
28 2PIROXICAM
29 1POLYETHYLENE GLYCOL 3350
30 4POMALIDOMIDE
31 2POTASSIUM CHLORIDE
32 3RIVASTIGMINE
33 2ROFLUMILAST
34 2SOLIFENACIN SUCCINATE
35 1SUCCINYLCHOLINE CHLORIDE
36 1TERBINAFINE HYDROCHLORIDE
37 2TERIFLUNOMIDE
38 2TETRACYCLINE HYDROCHLORIDE
39 1TOFACITINIB
40 2TRIAZOLAM
41 3TRIMIPRAMINE MALEATE
42 1ZOLEDRONIC ACID
43 2ZOLPIDEM TARTRATE
Reset all filters
01 81BRECKENRIDGE
02 9BRECKENRIDGE PHARM
03 1BRECKENRIDGE PHARMS
Reset all filters
01 7CAPSULE, DELAYED REL PELLETS;ORAL
02 16CAPSULE;ORAL
03 3FILM, EXTENDED RELEASE;TRANSDERMAL
04 1FOR SOLUTION;ORAL
05 5INJECTABLE;INJECTION
06 1INJECTABLE;INTRAVENOUS
07 4POWDER;INTRAVENOUS
08 1SOLUTION/DROPS;OPHTHALMIC
09 1SOLUTION;INTRAVENOUS
10 4TABLET, EXTENDED RELEASE;ORAL
11 45TABLET;ORAL
12 3TABLET;SUBLINGUAL
Reset all filters
01 10.05%
02 10.125MG
03 20.25MG
04 10.2MG/ML
05 20.5MG
06 10.5MG;0.1MG
07 10.75MG
08 2100MG
09 1100MG/VIAL
10 110MEQ
11 610MG
12 110MG/ML
13 110MG/VIAL
14 112.5MG
15 1125MG
16 113.3MG/24HR
17 114MG
18 3150MG
19 117GM/SCOOPFUL
20 31MG
21 11MG;0.5MG
22 42.5MG
23 120MEQ
24 220MG
25 120MG/ML
26 1250MCG
27 3250MG
28 325MG
29 125MG/VIAL
30 12MG
31 1300MG
32 13MG
33 14.6MG/24HR
34 140MG
35 14MG
36 1500MCG
37 1500MG
38 250MG
39 150MG/ML
40 65MG
41 16.25MG
42 1600MG
43 160MG/1.5ML (40MG/ML)
44 160MG/VIAL
45 17.5MG
46 175MG
47 17MG
48 19.5MG/24HR
49 1EQ 100MG BASE
50 2EQ 10MG BASE
51 1EQ 110MG BASE
52 1EQ 150MG BASE
53 1EQ 1MG BASE/ML
54 1EQ 2.5MG BASE
55 1EQ 20MG BASE
56 1EQ 250MG BASE
57 1EQ 25MG BASE
58 1EQ 30MG BASE
59 1EQ 40MG BASE
60 1EQ 4MG BASE/5ML
61 1EQ 50MG BASE
62 1EQ 5MG BASE
63 1EQ 60MG BASE
64 1EQ 75MG BASE
Reset all filters
01 91USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : ACETAZOLAMIDE
Dosage Strength : 125MG
Packaging :
Approval Date : 2020-04-30
Application Number : 207503
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : ACETAZOLAMIDE
Dosage Strength : 250MG
Packaging :
Approval Date : 2020-04-30
Application Number : 207503
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : AMITRIPTYLINE HYDROCHLORI...
Dosage Strength : 10MG
Packaging :
Approval Date : 2022-06-06
Application Number : 216243
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : AMITRIPTYLINE HYDROCHLORI...
Dosage Strength : 25MG
Packaging :
Approval Date : 2022-06-06
Application Number : 216243
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : AMITRIPTYLINE HYDROCHLORI...
Dosage Strength : 50MG
Packaging :
Approval Date : 2022-06-06
Application Number : 216243
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : AMITRIPTYLINE HYDROCHLORI...
Dosage Strength : 75MG
Packaging :
Approval Date : 2022-06-06
Application Number : 216243
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : AMITRIPTYLINE HYDROCHLORI...
Dosage Strength : 100MG
Packaging :
Approval Date : 2022-06-06
Application Number : 216243
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : AMITRIPTYLINE HYDROCHLORI...
Dosage Strength : 150MG
Packaging :
Approval Date : 2022-06-06
Application Number : 216243
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : APIXABAN
Dosage Strength : 2.5MG
Packaging :
Approval Date : 2021-07-26
Application Number : 209845
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : APIXABAN
Dosage Strength : 5MG
Packaging :
Approval Date : 2021-07-26
Application Number : 209845
Regulatory Info : DISCN
Registration Country : USA